Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Committee hears evidence and industry concerns on bill to phase out DEHP in IV bags and tubing

House Health Care and Wellness Committee · January 23, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

HB 2,402 would phase out DEHP and other orthophthalates in IV solution containers (effective 1/1/2028) and later tubing (1/1/2035); advocates cited health and environmental risks and pointed to alternatives, while manufacturers and hospital groups urged longer timelines and supply‑chain/implementation safeguards.

Committee staff summarized House Bill 2,402 for the Jan. 23 hearing, explaining the bill would ban IV solution containers with intentionally added DEHP or with unintended DEHP at or above 0.1% weight‑by‑weight beginning Jan. 1, 2028, and extend the prohibition to IV tubing beginning Jan. 1, 2035. Exemptions would include certain human blood collection and cell‑therapy kits and related products.

Environmental and public‑health witnesses urged lawmakers to adopt the bill. Heather Trim of Zero Waste Washington said phthalates are persistent in landfill leachate and can harm wildlife and reproductive health; she noted California…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans